Harrow Health (HROW) Debt/Equity Ratio: History & Chart

Harrow Health, Inc.(HROW)

Drug Manufacturers - Specialty & Generic · Nashville, TN

$30.18-0.40 (-1.32%)

Delayed quote: Oct 6, 2026, 11:15 AM EDT

About Harrow Health, Inc.

Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several pharmaceutical ventures. These encompass Surface Ophthalmics, Inc., a clinical-stage firm actively developing and commercializing therapeutic agents for ocular surface diseases; Melt Pharmaceuticals, Inc., another clinical-stage entity concentrating on proprietary non-intravenous sedation and anesthesia treatments for various medical procedures conducted in hospital, outpatient, and office environments; and Eton Pharmaceuticals, Inc., a commercial-stage company involved in the creation and market launch of drug products. Moreover, Harrow Health holds royalty interests in four investigational drug candidates currently being advanced by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company, initially incorporated in 2006 and based in San Diego, California, underwent a name change from Imprimis Pharmaceuticals, Inc. to Harrow Health, Inc. in December 2018.

Nashville, TN

373 employees

www.harrow.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mark L. Baum

View full financials

HROW Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

19.79

DEBT TO EQUITY RATIO AVG TTM

9.02

DEBT TO EQUITY RATIO AVG 3Y

4.10

DEBT TO EQUITY RATIO AVG 5Y

5.49

DEBT TO EQUITY RATIO AVG 10Y

3.49

DEBT TO EQUITY RATIO AVG 15Y

2.07

DEBT TO EQUITY RATIO AVG 20Y

1.62

CURRENT VS TTM AVG

+119.46%

CURRENT VS 3Y AVG

+382.14%

CURRENT VS 5Y AVG

+260.11%

CURRENT VS 10Y AVG

+467.43%

CURRENT VS 15Y AVG

+858.05%

CURRENT VS 20Y AVG

+1121.10%

SECTOR MEDIAN · HEALTHCARE

0.13

median of 589 covered companies

CURRENT VS SECTOR MEDIAN

+15119.84%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
Harrow Health, Inc. (HROW)	$1.12B	19.79	9.02	4.10	5.49
Amphastar Pharmaceuticals, Inc. (AMPH)vs ›	$1.13B	0.90	0.86	0.72	0.55
Damora Therapeutics, Inc. (DMRA)vs ›	$1.13B	0.00	0.05	0.03	0.02
OPKO Health, Inc. (OPK)vs ›	$1.14B	0.33	0.35	0.29	0.25
GoodRx Holdings, Inc. (GDRX)vs ›	$1.15B	0.83	0.81	0.86	0.88
Bicara Therapeutics Inc. Common Stock (BCAX)vs ›	$1.10B	0.00	0.00	0.00	0.00
Avalyn Pharma Inc. Common Stock (AVLN)vs ›	$1.16B	0.04	N/A	N/A	N/A
IRadimed Corporation (IRMD)vs ›	$1.08B	0.00	0.00	0.01	0.02
Nektar Therapeutics (NKTR)vs ›	$1.17B	0.15	1.67	1.15	0.83
Cullinan Therapeutics, Inc. (CGEM)vs ›	$1.07B	0.01	0.01	0.01	0.01

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

Harrow Health, Inc. (HROW)

$1.12B

19.79

9.02

4.10

5.49

Amphastar Pharmaceuticals, Inc. (AMPH)vs ›

$1.13B

0.90

0.86

0.72

0.55

Damora Therapeutics, Inc. (DMRA)vs ›

$1.13B

0.00

0.05

0.03

0.02

OPKO Health, Inc. (OPK)vs ›

$1.14B

0.33

0.35

0.29

0.25

GoodRx Holdings, Inc. (GDRX)vs ›

$1.15B

0.83

0.81

0.86

0.88

Bicara Therapeutics Inc. Common Stock (BCAX)vs ›

$1.10B

0.00

Avalyn Pharma Inc. Common Stock (AVLN)vs ›

$1.16B

0.04

N/A

IRadimed Corporation (IRMD)vs ›

$1.08B

0.00

0.01

0.02

Nektar Therapeutics (NKTR)vs ›

$1.17B

0.15

1.67

1.15

0.83

Cullinan Therapeutics, Inc. (CGEM)vs ›

$1.07B

0.01

Debt to Equity Ratio FAQ

What is the debt to equity ratio for Harrow Health, Inc. (HROW)?

The debt to equity ratio for HROW stock is 19.79.

Is Harrow Health, Inc.'s debt to equity ratio high or low?

The debt to equity ratio of 19.79 is 260% above its 5-year average of 5.49, near the low end of its 5-year range (2.50–66.12).

What is the TTM average debt to equity ratio for Harrow Health, Inc. (HROW)?

The TTM average debt to equity ratio for HROW stock is 9.02.

What is the 3Y average debt to equity ratio for Harrow Health, Inc. (HROW)?

The 3Y average debt to equity ratio for HROW stock is 4.10.

What is the 5Y average debt to equity ratio for Harrow Health, Inc. (HROW)?

The 5Y average debt to equity ratio for HROW stock is 5.49.

What is the 10Y average debt to equity ratio for Harrow Health, Inc. (HROW)?

The 10Y average debt to equity ratio for HROW stock is 3.49.

What is the 15Y average debt to equity ratio for Harrow Health, Inc. (HROW)?

The 15Y average debt to equity ratio for HROW stock is 2.07.

What is the 20Y average debt to equity ratio for Harrow Health, Inc. (HROW)?

The 20Y average debt to equity ratio for HROW stock is 1.62.

DATE	DEBT TO EQUITY RATIO
2026-06-30	19.79
2026-03-31	10.47
2025-12-31	4.80
2025-09-30	5.36
2025-06-30	4.66
2025-03-31	4.07
2024-12-31	3.29
2024-09-30	3.38
2024-06-30	3.29
2024-03-31	3.16
2023-12-31	2.71
2023-09-30	2.50
2023-06-30	7.92
2023-03-31	8.08
2022-12-31	4.07
2022-09-30	66.12
2022-06-30	13.98
2022-03-31	7.84
2021-12-31	6.91
2021-09-30	4.61
2021-06-30	3.30
2021-03-31	0.74
2020-12-31	0.87
2020-09-30	0.96
2020-06-30	1.54
2020-03-31	1.37
2019-12-31	0.76
2019-09-30	0.85
2019-06-30	0.59
2019-03-31	0.57
2018-12-31	0.62
2018-09-30	3.43
2018-06-30	4.10
2018-03-31	184.55
2017-12-31	5.86
2017-09-30	4.09
2017-06-30	1.75
2017-03-31	2.61
2016-12-31	2.13
2016-09-30	4.10
2016-06-30	1.68
2016-03-31	1.04
2015-12-31	-6.03
2015-09-30	3.67
2015-06-30	1.55
2015-03-31	0.01
2014-12-31	0.01
2014-09-30	0.00
2014-06-30	0.00
2014-03-31	0.00
2013-12-31	0.00
2013-09-30	0.00
2013-06-30	0.00
2013-03-31	0.00
2012-12-31	0.00
2012-09-30	0.00
2012-06-30	0.00
2012-03-31	-0.86
2011-12-31	-0.84
2011-09-30	-0.71
2011-06-30	-0.72
2011-03-31	-0.77
2010-12-31	-1.02
2010-09-30	0.00
2010-06-30	0.00
2010-03-31	0.00
2009-12-31	0.00
2009-09-30	0.00
2009-06-30	0.00
2009-03-31	0.00
2008-12-31	0.00
2008-09-30	0.00
2008-06-30	0.00
2008-03-31	0.00
2007-12-31	0.00
2007-09-30	0.00
2007-05-31	0.00
2007-02-28	0.00
2006-11-30	0.00
2006-08-31	0.00

DATE

DEBT TO EQUITY RATIO

2026-06-30

19.79

2026-03-31

10.47

2025-12-31

4.80

2025-09-30

5.36

2025-06-30

4.66

2025-03-31

4.07

2024-12-31

3.29

2024-09-30

3.38

2024-06-30

3.29

2024-03-31

3.16

2023-12-31

2.71

2023-09-30

2.50

2023-06-30

7.92

2023-03-31

8.08

2022-12-31

4.07

2022-09-30

66.12

2022-06-30

13.98

2022-03-31

7.84

2021-12-31

6.91

2021-09-30

4.61

2021-06-30

3.30

2021-03-31

0.74

2020-12-31

0.87

2020-09-30

0.96

2020-06-30

1.54

2020-03-31

1.37

2019-12-31

0.76

2019-09-30

0.85

2019-06-30

0.59

2019-03-31

0.57

2018-12-31

0.62

2018-09-30

3.43

2018-06-30

4.10

2018-03-31

184.55

2017-12-31

5.86

2017-09-30

4.09

2017-06-30

1.75

2017-03-31

2.61

2016-12-31

2.13

2016-09-30

4.10

2016-06-30

1.68

2016-03-31

1.04

2015-12-31

-6.03

2015-09-30

3.67

2015-06-30

1.55

2015-03-31

0.01

2014-12-31

0.01

2014-09-30

0.00

2014-06-30

0.00

2014-03-31

0.00

2013-12-31

0.00

2013-09-30

0.00

2013-06-30

0.00

2013-03-31

0.00

2012-12-31

0.00

2012-09-30

0.00

2012-06-30

0.00

2012-03-31

-0.86

2011-12-31

-0.84

2011-09-30

-0.71

2011-06-30

-0.72

2011-03-31

-0.77

2010-12-31

-1.02

2010-09-30

0.00

2010-06-30

0.00

2010-03-31

0.00

2009-12-31

0.00

2009-09-30

0.00

2009-06-30

0.00

2009-03-31

0.00

2008-12-31

0.00

2008-09-30

0.00

2008-06-30

0.00

2008-03-31

0.00

2007-12-31

0.00

2007-09-30

0.00

2007-05-31

0.00

2007-02-28

0.00

2006-11-30

0.00

2006-08-31

0.00

Debt to Equity Ratio: 19.79

HROW Debt to Equity Ratio

HROW Average Debt to Equity Ratio Chart

HROW Current vs Average Debt to Equity Ratio Chart

HROW Debt to Equity Ratio Metrics

HROW Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

HROW Debt to Equity Ratio History

Related Metrics